These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19437353)

  • 1. Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas.
    Bhat P; Jakobiec FA; Folberg R
    Semin Ophthalmol; 2009; 24(3):166-71. PubMed ID: 19437353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasculogenic mimicry and tumor angiogenesis.
    Folberg R; Hendrix MJ; Maniotis AJ
    Am J Pathol; 2000 Feb; 156(2):361-81. PubMed ID: 10666364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.
    Hendrix MJ; Seftor EA; Hess AR; Seftor RE
    Nat Rev Cancer; 2003 Jun; 3(6):411-21. PubMed ID: 12778131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasculogenic mimicry--potential target for tumor therapy].
    Yue WY; Chen ZP
    Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasculogenic mimicry.
    Folberg R; Maniotis AJ
    APMIS; 2004; 112(7-8):508-25. PubMed ID: 15563313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
    Maniotis AJ; Folberg R; Hess A; Seftor EA; Gardner LM; Pe'er J; Trent JM; Meltzer PS; Hendrix MJ
    Am J Pathol; 1999 Sep; 155(3):739-52. PubMed ID: 10487832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma.
    Meir T; Zeschnigk M; Masshöfer L; Pe'er J; Chowers I
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):1918-22. PubMed ID: 17460242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma.
    Massi D; Franchi A; Paglierani M; Ketabchi S; Borgognoni L; Reali UM; Santucci M
    Hum Pathol; 2004 Apr; 35(4):496-502. PubMed ID: 15116332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
    Hess AR; Seftor EA; Gardner LM; Carles-Kinch K; Schneider GB; Seftor RE; Kinch MS; Hendrix MJ
    Cancer Res; 2001 Apr; 61(8):3250-5. PubMed ID: 11309274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma.
    Warso MA; Maniotis AJ; Chen X; Majumdar D; Patel MK; Shilkaitis A; Gupta TK; Folberg R
    Clin Cancer Res; 2001 Mar; 7(3):473-7. PubMed ID: 11297236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma.
    Thies A; Mangold U; Moll I; Schumacher U
    J Pathol; 2001 Dec; 195(5):537-42. PubMed ID: 11745688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas.
    Onken MD; Lin AY; Worley LA; Folberg R; Harbour JW
    Am J Ophthalmol; 2005 Oct; 140(4):748-9. PubMed ID: 16226537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma.
    Clarijs R; Otte-Höller I; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):912-8. PubMed ID: 11923228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microcirculation patterns in different stages of melanoma growth.
    Zhang S; Guo H; Zhang D; Zhang W; Zhao X; Ren Z; Sun B
    Oncol Rep; 2006 Jan; 15(1):15-20. PubMed ID: 16328029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity.
    Chen X; Maniotis AJ; Majumdar D; Pe'er J; Folberg R
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2533-9. PubMed ID: 12147581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
    Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; Margaryan NV; Seftor RE; Miyagi Y; Hendrix MJ
    Cancer Res; 2003 Sep; 63(17):5381-9. PubMed ID: 14500372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumor angiogensis in uveal melanoma. Role of vascular endothelial growth factor (VEGF)].
    Proniewska-Skretek E; Mariak Z
    Klin Oczna; 2004; 106(4-5):682-5. PubMed ID: 15646494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas.
    Sun B; Zhang S; Zhao X; Zhang W; Hao X
    Int J Oncol; 2004 Dec; 25(6):1609-14. PubMed ID: 15547697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microcirculation of choroidal and ciliary body melanomas.
    Folberg R; Mehaffey M; Gardner LM; Meyer M; Rummelt V; Pe'er J
    Eye (Lond); 1997; 11 ( Pt 2)():227-38. PubMed ID: 9349418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of microcirculation patterns and MIB-1 immunoreactivity in iris and posterior uveal melanoma.
    Chowers I; Folberg R; Livni N; Pe'er J
    Ophthalmology; 2001 Feb; 108(2):367-71. PubMed ID: 11158814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.